BGHBX Holdings — Baillie Gifford Health Innovation Equities Fund
All 38 reported holdings of Baillie Gifford Health Innovation Equities Fund (BGHBX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Argenx SE | 7.58% | $522.31K |
| Alnylam Pharmaceuticals Inc | 7.11% | $489.83K |
| ALK-Abello A/S | 5.61% | $386.84K |
| Ambu A/S | 5.10% | $351.70K |
| Genmab A/S | 4.41% | $304.25K |
| Insulet Corp | 4.26% | $293.73K |
| Exact Sciences Corp | 4.07% | $280.79K |
| ResMed Inc | 3.89% | $267.80K |
| Moderna Inc | 3.72% | $256.43K |
| Doximity Inc | 3.61% | $248.96K |
| Sartorius AG | 3.59% | $247.72K |
| Illumina Inc | 3.57% | $245.82K |
| Novo Nordisk A/S | 3.46% | $238.17K |
| Edwards Lifesciences Corp | 3.30% | $227.34K |
| Veeva Systems Inc | 3.27% | $225.40K |
| Ascendis Pharma A/S | 3.26% | $224.86K |
| Zealand Pharma A/S | 3.11% | $214.14K |
| Vertex Pharmaceuticals Inc | 2.86% | $197.19K |
| Dexcom Inc | 2.76% | $190.33K |
| Denali Therapeutics Inc | 2.24% | $154.39K |
| BioNTech SE | 1.94% | $133.38K |
| Ionis Pharmaceuticals Inc | 1.62% | $111.65K |
| STAAR Surgical Co | 1.60% | $110.60K |
| Wuxi Biologics Cayman Inc | 1.56% | $107.23K |
| Twist Bioscience Corp | 1.51% | $104.05K |
| Schott Pharma AG & Co KGaA | 1.30% | $89.79K |
| M3 Inc | 1.25% | $86.12K |
| Inspire Medical Systems Inc | 1.18% | $81.04K |
| RxSight Inc | 1.03% | $71.28K |
| Health Catalyst Inc | 1.03% | $71.10K |
| 10X Genomics Inc | 0.95% | $65.28K |
| Exscientia Plc | 0.85% | $58.56K |
| Recursion Pharmaceuticals Inc | 0.76% | $52.13K |
| Zai Lab Ltd | 0.72% | $49.91K |
| Alector Inc | 0.37% | $25.73K |
| Lyell Immunopharma Inc | 0.22% | $15.03K |
| Vir Biotechnology Inc | 0.16% | $11.13K |
| Sana Biotechnology Inc | 0.13% | $8.99K |
BGHBX overview: performance, fees, allocation and SEC filings